Location History:
- Whippany, NJ (US) (2010)
- Shrewsbury, MA (US) (2012)
Company Filing History:
Years Active: 2010-2012
Title: **Pintipa Grongsaard: Innovator in Sphingosine-1-Phosphate Research**
Introduction
Pintipa Grongsaard is a prominent inventor based in Shrewsbury, Massachusetts, recognized for his contributions to pharmaceutical advancements. With two patents to his name, he focuses on developing novel compounds that target critical receptors in the body related to various medical conditions. His work has significant implications for therapeutic approaches, particularly in immunosuppressive treatments.
Latest Patents
Pintipa Grongsaard's latest patents include groundbreaking innovations that are making waves in the field of pharmacology. The first patent, titled "Sphingosine-1-phosphate receptor agonist and antagonist compounds," highlights the development of novel, potent, and selective agents. These agents act as either agonists or antagonists of the individual receptors of the S1P receptor family, showing promise for treating various medical conditions.
The second patent, focusing on "Oxadiazole compounds," presents new oxadiazole compounds and their pharmaceutical compositions. These compounds are demonstrated to be effective as agonists or antagonists of the S1P family of G protein-coupled receptors, especially in providing beneficial immunosuppressive effects for treating diseases linked to receptor activity modulation.
Career Highlights
Pintipa Grongsaard is currently affiliated with Abbott Laboratories Corporation, a globally recognized leader in healthcare innovations. Throughout his career, he has been dedicated to advancing the understanding and application of pharmacological treatments. His relentless pursuit of innovation has positioned him as a key contributor in his field, influencing therapeutic practices and improving patient outcomes.
Collaborations
During his tenure at Abbott Laboratories Corporation, Pintipa has collaborated with esteemed colleagues, including Adrian Hobson and Shannon R Fix-Stenzel. These partnerships have enhanced his research efforts and resulted in a synergistic approach to developing new therapeutic agents that address critical medical needs.
Conclusion
Pintipa Grongsaard exemplifies the spirit of innovation in the realm of pharmaceuticals. With his pioneering patents and collaborative efforts, he continues to make significant strides in developing compounds that could change treatment paradigms for various diseases. His work not only showcases his dedication as an inventor but also holds promise for future advancements in medical science.